Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments.

Affiliation

Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, 40138, Bologna, Italy. [Email]

Abstract

During the last few years, the gut microbiota has gained increasing attention as a consequence of its emerging role as a modulator of the immune system. With the advent of the era of checkpoint inhibitors immunotherapy and adoptive cell transfer (ACT) in oncology, these findings became of primary relevance in light of experimental data that suggested the microbiota involvement as a plausible predictor of a good or poor response. These remarks justify the efforts to pinpoint the specific actions of the microbiota and to identify new strategies to favorably edit its composition.

Keywords

CAR T-cell,TCR,TIL,adoptive cell transfer (ACT),cancer,checkpoint inhibitors,diet,immuno-oncology,immunotherapy,microbiome,microbiota,

OUR Recent Articles